Geistlich Pharma
Bahnhofstrasse 40
Wolhusen
6110
Tel: 41-41-492-55-55
Fax: 41-41-492-56-39
Website: http://www.geistlich-pharma.com/
Email: info@geistlich.ch
About Geistlich Pharma
Geistlich Pharma is specialised in biomaterials for the regeneration of bone, cartilage and tissue and develops and manufactures medical devices and pharmaceuticals with the goal of giving patients a better quality of life.LEADERSHIP:
CEO: Paul Note
COO: Mario Mucha
CFO: Rolf Jeger
CSO: Terance Hart
JOBS:
Please click here for Geistlich Pharma job opportunities.
7 articles about Geistlich Pharma
-
Geistlich Pharma AG Executive Chairman, Dr. Andreas Geistlich, Honored with AAOMS Special Citation Award
10/2/2023
Geistlich Pharma North America Inc. is pleased to announce that our Executive Chairman, Dr. Andreas Geistlich, has been awarded the prestigious American Association of Oral and Maxillofacial Surgeons Board of Trustees Special Citation Award for the company's exceptional and longstanding contributions to the field of Oral and Maxillofacial Surgery.
-
New Level-1 Evidence Finds Geistlich Derma-Gide® Closes Significantly More Diabetic Foot Ulcers in Appreciably Shorter Time and at Lower Costs
1/11/2022
The Geistlich Medical business unit of Geistlich Pharma AG, a family owned, Swiss-based global leader in regenerative solutions, is proud to announce the results from their clinical study of the Geistlich Derma-Gide® Advanced Wound Matrix.
-
Geistlich Pharma Launches Geistlich Nexo-Gide® Dual Surface Membrane for Tendon Management and Protection
11/3/2021
The Geistlich Surgery, USA business unit of Geistlich Pharma AG, a family owned, Swiss-based global leader in regenerative solutions, is proud to announce the launch of its latest advancement: Geistlich Nexo-Gide® Dual Surface Membrane.
-
Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide® Articular Cartilage Cover
2/2/2021
Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide ® Articular Cartilage Cover
-
Geistlich Bio-Gide® Portfolio Expands
4/10/2018
The Collagen Expert, Geistlich Biomaterials Launches Two NEW Resorbable Collagen Membranes to Enhance Clinical Procedures
-
Geistlich Pharma North America Has New VP of Scientific and Clinical Affairs
11/8/2017
Dr. Panagakos will lead the U.S. clinical science team activities related to the development of clinical studies, publications, and continuing to strengthen relationships with regional and national professional associations aligned with regenerative dentistry.
-
Geistlich Pharma Opens Tenth Subsidiary
10/12/2016